Rocket Pharmaceuticals Warrant
RCKTW
14 hedge funds and large institutions have $1M invested in Rocket Pharmaceuticals Warrant in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0.1% more ownership
Funds ownership: 3.64% → 3.74% (+0.1%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
7% less funds holding
Funds holding: 15 → 14 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
50% less capital invested
Capital invested by funds: $2.01M → $1M (-$1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$19.4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$657 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$12.9K |
| 2 |
CAC
Cowen and Company
New York
|
-$8.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$9 |
RCKTW Hedge Fund Activity: Q2 2024 in Review
14 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals Warrant (RCKTW) for Q2 2024, worth a combined $1M — down 50% from $2.01M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of RCKTW and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $19.4K. The largest seller was Pura Vida Investments, exiting entirely with an estimated $12.9K sold.
- 14 institutional investors held Rocket Pharmaceuticals Warrant (RCKTW) as of Q2 2024, down from 15 in Q1 2024.
- Funds reported $1M of Rocket Pharmaceuticals Warrant stock for Q2 2024, down 50% quarter-over-quarter.
- 1 fund opened new Rocket Pharmaceuticals Warrant positions in Q2 2024 and 2 closed out, a net change of -1 holder.
- The largest Rocket Pharmaceuticals Warrant buyer in Q2 2024 was Susquehanna International Group, an estimated $19.4K added.
- The largest Rocket Pharmaceuticals Warrant seller in Q2 2024 was Pura Vida Investments, an estimated $12.9K sold.
Based on aggregated 13F filings for Q2 2024.